Kristen Albright, PharmD
CEO, Prokarium
2025 Advisory Committee
Sarah Alspach
Mara Aspinall
Partner, Illumina Ventures
Martha Azer
Associate Director, Global Regulatory Policy & Intelligence, Johnson & Johnson Innovative Medicine
Abi Barrow
Managing Partner, Cambridge Innovation Partners
Karen Boezi
Chief Operating Officer, Thirona Biosciences
Ted Buckley, PhD
Vice President, Government Affairs, Shionogi
Hemmie Chang
Boston Office Managing Partner, Arnold & Porter
Helena Chaye, PhD
CEO, KaliVir
Sadhana Chitale
Senior Director, Life Sciences, Technology Transfer, New York University Langone Health
Azurii K. Collier, Ph.D.
Director, AbbVie
Drew Cutshaw, MD
Principal, Pappas Capital
Kelley Davenport
Head, Global Policy Communications, Amgen
Dean Edelman
Life Science Lead for Corporate Engagement, Princeton
Greg Frank
Director, Global Public Policy, Merck & Co.
Elizabeth Franklin, PhD
Head, US Public Affairs and Patient Advocacy, Oncology, Sanofi
Joydeep Ganguly
Senior Vice President of Corporate Operations, and Chief Sustainability Officer, Gilead Sciences
Gail Gannon
Founding Director, Neurotech Collider Lab, University of California, Berkeley
Luba Greenwood
Managing Partner, Binney Street Capital
Troy Groetken
Shareholder, Board Member and Executive Committee Member, McAndrews, Held & Malloy, Ltd
Anjali Gupta, PhD
CEO & Co-founder, ANYg.BIO
Mary Haak-Frendscho, PhD
CEO, Spotlight Therapeutics
Susie Harborth
Chief Business Officer, Breakthrough Properties
Christina Hochul
Amy House
Head of Portfolio Strategy, Beacon Therapeutics
Matthew Hudes
CEO, BdlBiologx
Ashley John
Director, Issue Advocacy, Novartis
Terrell Kingwood
Operations Manager - Strategic Operations, Health Equity & Organizational Health, Genentech
Ravi Kiron
Managing Director, Biopharm Strategy
Andrew Lam, PharmD
Managing Director, Head of Biotech Private Equity, Ally Bridge Group
Gabriela Lavezzari, PhD, MBA
Head of Digital Transformation & Innovation, GSK
Chris LeMasters
CEO, XinThera, a Gilead Company
Michelle Linn
Founder & CEO, Linnden Communications
Andrew McCandlish
COO, Revagenix, Inc.
Janet McNicholas, PhD
Chief Legal Officer, Invenra Inc.
Snehal Naik, PhD
Head of Regulatory Policy and Content Management, Spark Therapeutics
Kevin Noonan
Partner, McDonnell Boehnen Hulbert & Berghoff LLP
Daryl Pritchard, PhD
Senior Vice President, Policy and Government Affairs, Personalized Medicine Coalition
Suguna Rachakonda
VP, Head of Business Development, Dewpoint Therapeutics
Jim Schaeffer
Chief Business Officer, PhenoTarget Biosciences
Liz Schwarzbach
Chief Business Officer, BigHat Biosciences
Maude Tessier, PhD
Chief Business Officer, Seismic Therapeutic
Maia Thrift-Perry
Global Head, Patient Advocacy and Public Health Policy, BeiGene
Pam Traxel
Senior Vice President, American Cancer Society Cancer Action Network, Inc.
Arda Ural, PhD
Americas Life Sciences Sector Leader, EY (Ernst & Young)
Amy Walker, PhD
Director, US Policy & Advocacy, CSL Seqirus
Hanadie Yousef, PhD
CEO and co-founder, Juvena Therapeutics
Alex Zhavoronkov, PhD
Founder and CEO, Insilico Medicine